Varex Imaging

Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. It operates through the Medical and Industrial segments. The Medical segment delivers and services x-ray imaging components, including X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, and three-dimensional reconstruction software. The Industrial segment offers x-ray imaging products for use in security, and nondestructive testing and inspection applications. The company was founded in July 2016 and is headquartered in Salt Lake City, UT.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Varex Imaging meets Q1 expectations amidst gross margin challenges

Varex Imaging's Q1 performance met expectations, with revenue impacted by a less favorable product mix. The company faces challenges from cautious customer behavior and gross margin pressures but sees opportunities in the healthcare market, particularly in China.

Varex Imaging excels in Q2, plans expansion amid supply challenges

Varex Imaging delivered strong Q2 results, driven by robust performance in the Industrial segment and innovative projects in Medical and Industrial segments.
While facing supply chain challenges, the company aims to invest in expanding manufacturing capacity to address demand and ensure operational resilience.
With a positive outlook for fiscal 2023 and a focus on cost management, Varex is poised for continued growth and market leadership in the imaging industry.

Varex Imaging achieves record revenue in Q3 2023 earnings

Varex Imaging delivered a robust performance in Q3 2023, marked by record revenue, improved margins, and strong segment growth.
While facing supply chain and market challenges, the company remains optimistic about sustained growth and profitability.
Strategic focus on new products, margin enhancement, and key segment expansion positions Varex well for future success.

Varex Imaging posts strong Q4 results, eyes growth opportunities

Varex Imaging reports solid Q4 performance with revenue driven by Industrial segment. Challenges include decline in Medical segment revenue and anticipated revenue decrease in Q1 FY 2024. Company focuses on growth opportunities in photon counting technology, India expansion, and new product introductions.

Varex Imaging meets Q1 expectations, focuses on photon counting growth

Varex Imaging's Q1 performance met expectations, with revenue at $190 million and a focus on new product development in photon counting technology.
While facing challenges in certain modalities and markets, the company showcased strength in global Industrial sales and employee pride.
Opportunities lie in the photon counting technology for CT, revenue growth expectations for Q2, and stable operational environment post-supply chain issues.
Management's forward-looking approach towards customer successes and technology advancements positions Varex Imaging for future growth and market expansion.

Varex Imaging faces revenue challenges in China, eyes tech growth

Varex Imaging's Q2 performance reflected mixed results with revenue, gross margin, and EPS figures. While facing challenges from soft demand in China, the company is focusing on leveraging photon-counting technology for future growth opportunities.

Varex Imaging meets Q3 revenue expectations amidst market challenges

Varex Imaging's Q3 performance was solid, with strengths in cargo inspection products and financial stability.
Challenges in China and the Medical segment require strategic focus for sustained growth.
Opportunities lie in market improvements, managing demand effectively, and exploring new growth avenues.

Varex Imaging reports resilient Q4 performance and outlines growth strategies

Varex Imaging's Q4 performance showcased revenue resilience in the industrial segment but faced challenges in medical segment revenue.
The company's strategic focus on innovation and expansion presents growth opportunities in dynamic markets.
Balancing revenue diversification, margin maintenance, and operational efficiency will be key for future success.
Anticipated revenue growth in Q1 2025 with a range of $195-215 million and varied EPS expectations.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. It operates through the Medical and Industrial segments. The Medical segment delivers and services x-ray imaging components, including X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, and three-dimensional reconstruction software. The Industrial segment offers x-ray imaging products for use in security, and nondestructive testing and inspection applications. The company was founded in 2016 and is headquartered in Salt Lake City, UT.

Varex Imaging's (VREX) CEO Sunny Sanyal on Q1 2022 Results - Earnings Call Transcript

SALT LAKE CITY--(BUSINESS WIRE)--Varex Announces Financial Results for First Quarter Fiscal Year 2022

Varex Announces Financial Results for First Quarter Fiscal Year 2022

SALT LAKE CITY--(BUSINESS WIRE)--Varex Schedules First Quarter Fiscal Year 2022 Earnings Release and Conference Call

Varex Schedules First Quarter Fiscal Year 2022 Earnings Release and Conference Call

The company is recovering from the steep losses it experienced during the height of the COVID-19 pandemic.

Here's What Investors Need to Know About Varex Imaging's Q4 Earnings

The stock price of Varex Imaging Corp (NASDAQ: VREX) increased by 11.96% yesterday. This is why it happened.

Varex Imaging (VREX) Stock: Why The Price Jumped

Varex Imaging Corporation (VREX) CEO Sunny Sanyal on Q4 2021 Results - Earnings Call Transcript

Varex Imaging (NASDAQ:VREX) reported its Q4 earnings results on Tuesday, November 16, 2021 at 04:05 PM. Here's what investors need to know about the announcement.

Varex Imaging: Q4 Earnings Insights

SALT LAKE CITY--(BUSINESS WIRE)--Varex Announces Record Financial Results for Fourth Quarter and Fiscal Year 2021

Varex Announces Record Financial Results for Fourth Quarter and Fiscal Year 2021

Varex Imaging (NASDAQ: VREX) is set to give its latest quarterly earnings report on Tuesday, 2021-11-16. Here's what investors need to know before the announcement.

Earnings Preview For Varex Imaging

SALT LAKE CITY--(BUSINESS WIRE)--Varex Schedules Fourth Quarter and Fiscal Year 2021 Earnings Release and Conference Call

Varex Schedules Fourth Quarter and Fiscal Year 2021 Earnings Release and Conference Call

VAREX IMAGING (VREX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Earnings Estimates Moving Higher for VAREX IMAGING (VREX): Time to Buy?

IDEXX Laboratories

Omnicell

STAAR Surgical

Investors can choose to invest in MedTech stocks like VREX, OMCL, STAA, and IDXX that have shown tremendous promise amid the pandemic.

4 MedTechs to Gain in 2H21 Beating the Delta Variant-Led Dip

Varex Imaging Corporation's (VREX) CEO Sunny Sanyal on Q3 2021 Results - Earnings Call Transcript

VAREX IMAGING (VREX) delivered earnings and revenue surprises of 48.15% and 2.95%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

VAREX IMAGING (VREX) Q3 Earnings and Revenues Top Estimates

SALT LAKE CITY--(BUSINESS WIRE)--Varex Announces Financial Results for Third Quarter Fiscal 2021

Varex Announces Financial Results for Third Quarter Fiscal Year 2021

VAREX IMAGING (VREX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

VAREX IMAGING (VREX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Schedules Third Quarter Fiscal Year 2021 Earnings Release and Conference Call

Varex Schedules Third Quarter Fiscal Year 2021 Earnings Release and Conference Call

SALT LAKE CITY--(BUSINESS WIRE)--VAREX ANNOUNCES LUMEN 4336W RADIOGRAPHY DETECTOR WITH IP68 RATING

Varex Announces LUMEN 4336W Radiography Detector With IP68 Rating

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that it is scheduled to present at an upcoming virtual investor conference. Jefferies Virtual Healthcare Conference Varex will be presenting on Wednesday, June 2, 2021 at 9:30 am ET. The webcast link is: https://wsw.com/webcast/jeff174/vrex/1884627 The company's Chief Financial Officer, Sam Maheshwari, will provide an overview of Varex's business and prospects. Varex's presentation will be webcast and acce

Varex to Present at Jefferies Virtual Healthcare Conference

Varex Imaging's (VREX) CEO Sunny Sanyal on Q1 2021 Results - Earnings Call Transcript

VAREX IMAGING (VREX) delivered earnings and revenue surprises of 94.44% and 8.25%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

VAREX IMAGING (VREX) Surpasses Q2 Earnings and Revenue Estimates

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter of fiscal year 2021. 2QFY21 Summary Revenues $204 million GAAP gross margin 32% | Non-GAAP gross margin* 35% GAAP operating expense $49 million | Non-GAAP operating expense* $45 million GAAP operating margin 8% | Non-GAAP operating margin* 13% GAAP net earnings $0.08 per diluted share | Non-GAAP net earnings* $0.35 per diluted share “Financial results

Varex Announces Financial Results for Second Quarter Fiscal Year 2021

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the second quarter of fiscal year 2021 following the close of regular trading on Tuesday, May 4, 2021. The earnings news release will be followed by a conference call at 3:00 p.m. Mountain Time that day. This call will be webcast live and can be accessed at the company's website at investors.vareximaging.com. Investors can also access this conference call

Varex Schedules Second Quarter Fiscal Year 2021 Earnings Release and Conference Call

Dropbox

National Energy Services Reunited

EnPro Industries

Steel Dynamics

Steel Dynamics (STLD), EnPro Industries (NPO) & Dropbox (DBX) are a few stocks for which the last two quarter-over-quarter percentage EPS growth rates exceeded the growth rates of the previous periods.

5 Top Stocks to Buy for Superb Earnings Acceleration

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that it is scheduled to present at an upcoming virtual investor conference. Oppenheimer 31st Annual Healthcare Conference Varex will be presenting on Wednesday, March 17, 2021 at 1:10 pm ET. The webcast link is: https://wsw.com/webcast/oppenheimer9/vrex/2767017 The company's Chief Financial Officer, Sam Maheshwari, will provide an overview of Varex's business and prospects. Varex's presentation will be web

News for Varex Imaging Stock (VREX)